Healthcare entity

Omid Farokhzad

Person

All 1 tracked stories fall under one category: market-trends. Omid Farokhzad is most often covered alongside David Gilboa, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 3.2 for the broader beat in this window.

Last mentioned: Feb 27, 2026

Entity pulse

Recent coverage · Omid Farokhzad

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Omid Farokhzad

All 1 tracked stories fall under one category: market-trends. Omid Farokhzad is most often covered alongside David Gilboa, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 3.2 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 5.7 in the same window. We currently track 1 Healthcare story that mention Omid Farokhzad, all published on February 27, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Omid Farokhzad. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Anticipated Milestones

    Expected expansion of WRBY's insurance network and SEER's multi-omics software updates.

  2. Market Analysis

    Analysts highlight the shift toward integrated health platforms in both consumer and clinical sectors.

  3. Q4 Earnings Calls

    Warby Parker and Seer, Inc. both report year-end results, outlining 2026 growth strategies.

Stories mentioning Omid Farokhzad 1

Omid Farokhzad is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.